Introduction
Overactive bladder (OAB) is a prevalent and disruptive urological disorder characterized by urinary urgency, frequency, and nocturia, affecting approximately 11–16% of adults globally, with a higher incidence in aging populations [1, 2]. The pathophysiology of OAB is primarily driven by detrusor overactivity and a dysregulated balance between oxidative stress and inflammatory responses [3]. Reactive oxygen species (ROS) and inflammatory cytokines, such as IL-6 and TNF-α, contribute to bladder dysfunction, impairing storage and voiding functions and significantly affecting patients’ quality of life [4].
Current pharmacological treatments for OAB, including anticholinergics, are limited by side effects and poor long-term compliance, highlighting the urgent need for effective non-pharmacological therapies. Recent studies suggest that exercise, particularly resistance training, may offer a promising alternative [5, 6]. Resistance exercise has been shown to reduce oxidative stress and inflammation in various chronic diseases, such as cardiovascular disease and diabetes, and emerging evidence indicates it may have similar benefits in OAB.
These constraints underscore a major unmet clinical need for safe, well-tolerated, and sustainable non-pharmacological interventions capable of modifying bladder pathophysiology rather than offering transient symptomatic relief [7, 8]. In this context, structured physical training, particularly resistance-based paradigms, has emerged as a promising yet underexplored strategy for improving bladder function through neuromuscular and metabolic reconditioning.
First-line management of OAB relies on anticholinergic drugs, but their clinical utility is limited by side effects (e.g., dry mouth and cognitive impairment) and poor long-term compliance [9]. Non-pharmacological strategies, such as pelvic floor muscle training (PFMT), are recommended as safer alternatives but yield modest efficacy (42% symptom improvement rate) due to suboptimal patient adherence and lack of mechanistic targeting [10, 11]. In recent years, resistance exercise, especially weighted belt training has emerged as a promising modality: preclinical studies demonstrate that resistance exercise reduces detrusor thickness and improves bladder capacity in OAB rodent models [12, 13], while clinical trials report alleviated urgency–frequency symptoms and reduced urinary incontinence episodes [14].
However, these studies suffer from two critical gaps: unstandardized exercise intensity, such as undefined weight-bearing protocols, and unclear mechanistic pathways (e.g., how exercise modulates oxidative stress and inflammation in the bladder microenvironment).
The clinical translation of resistance exercise for OAB is further hindered by three major challenges. First, excessive exercise intensity exacerbates musculoskeletal risks (e.g., joint injury and fractures) in older adults with sarcopenia or osteoporosis, while suboptimal intensity fails to elicit therapeutic effects [15]. Second, prior studies attribute OAB improvement to “general metabolic benefits”, but the specific molecular targets remain uncharacterized [16, 17].
Notably, peroxynitrite (PN), a cytotoxic oxidant generated by the reaction of nitric oxide (-NO) and superoxide (O2−), has been implicated in detrusor dysfunction via protein nitration and mitochondrial damage, yet its role in exercise-mediated OAB relief is unknown [18]. Third, rodent models of resistance exercise often use non-physiologic protocols (e.g., forced swimming), limiting extrapolation to human weight-bearing movements, such as weighted vest training [19]. Unlike historical “weighted-belt” paradigms that may confound the mechanobiological effects of training with elevated intra-abdominal pressure, our vest-based graded loading on a treadmill standardizes external workload as a fixed percentage of body weight and distributes it dorsally [20].
This configuration enhances reproducibility, reduces abdominal compression, and aligns more closely with prescription-style exercise used clinically.
Against this backdrop, we propose that resistance exercise alleviates OAB through a “resistance exercise–oxidative stress–detrusor remodelling” axis, where controlled mechanical loading reduces bladder oxidative stress, inhibits inflammatory cascades, and reverses pathological detrusor thickening, defined as abnormal smooth muscle hypertrophy underlying bladder hypercontractility [21]. Based on these considerations, we hypothesized that low-intensity resistance exercise alleviates OAB by reducing detrusor oxidative stress through peroxynitrite suppression. To test this hypothesis, we established a cyclophosphamide (CYP)-induced OAB rat model and applied graded resistance exercise regimens to determine the optimal therapeutic intensity.
Using integrated urodynamic, imaging, histological, and metabolomic analyses, we evaluated the “resistance exercise–oxidative stress–detrusor remodeling” axis. This study aims to elucidate the mechanistic basis of exercise-induced redox homeostasis in the bladder and provide a translational framework for personalized, mechanism-based exercise prescriptions for OAB management.
Materials and methods
Animal model and experimental design
Female Sprague–Dawley rats (7–9 weeks, 250 ± 20 g) were obtained from the Institutional Laboratory Animal Center. All procedures were conducted under specific pathogen-free (SPF) conditions (22 ± 2 °C, 50–60% humidity, 12-h light/dark cycle) with ad libitum access to food and water. Experimental protocols were approved by the Institutional Animal Care and Use Committee (Approval No.
2025-DWYY-044) and performed in compliance with the ARRIVE guidelines.
A total of 110 rats were randomly allocated into 11 experimental groups (n = 10/group) using a computer-generated randomization schedule (Fig. 1A; Table 1). The final grouping structure consisted of the control group, the CYP-induced OAB model group, and nine resistance-training subgroups that differed in load (5%, 10%, or 15% body weight) and duration (10, 20, or 30 min per session), as summarized in Table 1.
All animals were acclimated to treadmill running prior to the start of the intervention. Additional internal validation included sham-exercise rats (wearing unweighted belts) and sedentary time-matched controls. The groups included:Fig.
1Experimental design and workflow of resistance exercise intervention in OAB rat model. A Schematic diagram illustrating the experimental grouping and study design. Female Sprague–Dawley rats were divided into control and cyclophosphamide (CYP)-induced OAB model groups.
The model group was further subdivided according to resistance exercise intensity (5%, 10%, or 15% of body weight [BW]) and training duration (10, 20, or 30 min per day). Blank controls received no intervention. Comprehensive evaluations included: functional assessment (urine spot test, urodynamic testing, and pelvic muscle electrophysiology), imaging assessment (MRI-based bladder and detrusor thickness quantification), and histological analysis (HE and α-SMA staining, fast/slow muscle fiber evaluation).
B–G Representative images of the experimental setup and resistance training protocol. B Body weight measurement for individualized load calibration. C Custom-designed cotton vest with embedded steel beads for weight loading.
D Illustration of treadmill training system for resistance exercise. E Photograph of rat wearing the weighted vest during adaptation training. F Actual treadmill running under experimental conditions.
G Parallel operation setup showing multiple rats performing resistance exercise simultaneously. The treadmill incline (0°) and running speed progression are shown for direct comparison across all exercise subgroupsTable 1Tolerance and adverse events across experimental groups (n = 10 each)GroupLoad (% BW)Duration (min/session)Completion rate (%)Intolerance events (n)Serious adverse events (n)NotesControl0–10000Healthy control, no interventionOAB Model0–10000CYP-induced OAB, no training5% BW + 10 min51010000Fully tolerated5% BW + 20 min5209510One rat with transient fatigue5% BW + 30 min5309010Two rats missed ≥ 1 session10% BW + 10 min10109210Mild fatigue in one rat10% BW + 20 min10208820Reduced tolerance with longer duration10% BW + 30 min10308031One muscle strain requiring withdrawal15% BW + 10 min15108520Higher fatigue at short duration15% BW + 20 min15207831Intolerance frequent, one SAE15% BW + 30 min15307042Lowest completion, multiple SAECompletion rate = number of rats completing the full training protocol ÷ 10 × 100%. “Intolerance events” refer to non-severe adverse events (e.g., refusal, transient limp, and exhaustion) that caused temporary cessation of training but did not require removal from the study.
“Serious adverse events” (SAE) were defined as injuries (e.g., muscle strain and severe distress) that required veterinary intervention or removal from training. Treadmill training was performed on a flat incline (0°) with an initial speed of 10 m/min, increased gradually based on animal tolerance as described in Methods
(1) Normal control group (control)—no intervention;
(2) OAB model group (model)—cyclophosphamide (CYP)-induced OAB without exercise;
(3–11) Resistance exercise groups—OAB rats subjected to treadmill resistance training at different combinations of load intensity (5%, 10%, or 15% of body weight, BW) and daily duration (10, 20, or 30 min).
Induction of overactive bladder (OAB)
OAB was induced using intraperitoneal injections of cyclophosphamide (CYP, 75 mg/kg, 2.5% solution) on days 1, 4, and 7, a well-established protocol for chemical cystitis and detrusor overactivity. Injections were performed under aseptic conditions approximately 1 cm lateral to the midline–hindlimb intersection to reduce the risk of peritoneal injury or infection. Successful model establishment was verified by reduced effective bladder capacity, shortened voiding intervals, and increased urine spot area relative to controls, assessed prior to exercise intervention.
Resistance exercise protocol
After OAB induction, rats were equipped with custom-designed cotton vests containing small steel ball compartments for adjustable weight loading. Before formal training, all animals underwent a 7-day adaptive preconditioning period, consisting of progressive, no-load treadmill running (5–30 min/day) and incremental weight acclimatization (5–10% BW). Formal resistance training was then performed for 2 weeks on a motorized treadmill (8 m/min) under gentle stimulation to maintain consistent running speed.
The treadmill protocol began at a flat incline (0°) with a starting speed of 10 m/min, which was progressively increased by 1–2 m/min per week depending on tolerance. Each exercise subgroup received a specific combination of weight load (5%, 10%, or 15% BW) and duration (10, 20, or 30 min per day). Training was conducted between 8:00 and 10:00 a.m. to minimize circadian variation.
Completion rate, intolerance events (refusal, transient fatigue), and serious adverse events (e.g., muscle strain) were recorded daily. After the final session, rats were allowed a 24 h rest period before functional assessment.
Urine spot test
Bladder voiding patterns were evaluated using a urine spot test. Rats were placed individually in metabolic cages lined with 0.7 mm filter paper for 4 h under water restriction. Filter papers were air-dried and sprayed with 0.2% ninhydrin solution to visualize urine spots.
Images were acquired under uniform white light, and spot number and area were quantified using ImageJ software. Urine spot area served as an indirect measure of bladder capacity and urinary frequency.
Urodynamic testing
Bladder function was evaluated by cystometry under urethane anesthesia (20%, 1 g/kg, intraperitoneal). A PE-50 catheter (0.58 mm inner diameter) was inserted transurethrally and connected to a PowerLab data acquisition system (ADInstruments, Australia) to record intravesical pressure. Saline was continuously infused at 6 mL/h, and cystometric parameters were recorded, including: effective bladder capacity (EBC) = voiding interval × infusion rate (0.1 mL/min); Voiding interval (VI) = time between consecutive voiding contractions.
Simultaneous electromyography (EMG) of pelvic floor muscles was recorded using bipolar silver wire electrodes (0.05 mm diameter). All traces were analyzed offline to ensure reproducibility.
Magnetic resonance imaging (MRI)
To quantify detrusor muscle thickness, rats were anesthetized with 2% isoflurane in oxygen and scanned using a 7.0 T small-animal MRI system (Bruker, Germany). Rats were positioned supine with pelvic immobilization using foam pads. T2-weighted images were acquired in transverse, sagittal, and coronal planes (TR = 3000 ms, TE = 30 ms, slice thickness = 1 mm).
Bladder wall and detrusor layers were delineated manually in ImageJ by two blinded investigators, and the mean thickness across three slices was calculated for each rat.
Histological and immunohistochemical analysis
Bladders were excised immediately after euthanasia, fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned at 5 µm. Hematoxylin–eosin (HE) staining was performed to assess general morphology, detrusor muscle architecture, and inflammatory cell infiltration. Immunohistochemistry (IHC) for α-smooth muscle actin (α-SMA, 1:200) quantified smooth muscle fiber hypertrophy and orientation.
Immunofluorescence (IF) for 3-nitrotyrosine (3-NT, 1:100, Alexa Fluor 488) evaluated peroxynitrite-mediated protein nitration. Inflammation was graded semi-quantitatively (0–3 scale) based on neutrophil and lymphocyte density. Images were captured using an Olympus BX53 microscope, and quantitative analysis was performed using ImageJ.
Metabolomics profiling
Bladder tissues were snap-frozen in liquid nitrogen, homogenized, and extracted using methanol/water (1:1, v/v) containing isotopically labeled internal standards. Untargeted metabolomic profiling was performed using both LC–MS (Agilent 1290/6460) and GC–MS (Thermo ISQ–QD) platforms. Raw data were processed in XCMS for peak picking and alignment, followed by normalization and pathway analysis via MetaboAnalyst 5.0.
Differential metabolites were identified using variable importance in projection (VIP > 1) and p < 0.05, then annotated to KEGG pathways for enrichment analysis.
Statistical analysis
All data are expressed as mean ± standard deviation (SD). Group comparisons were conducted using one-way ANOVA followed by Tukey’s post-hoc test. For nonparametric data, the Kruskal–Wallis test with Dunn’s multiple-comparison correction was used.
Statistical analyses were performed with SPSS 26.0 and GraphPad Prism 10.0. Significance was defined as p < 0.05. All experiments were performed in accordance with the ARRIVE guidelines and reported following the CONSORT 2010 statement for preclinical animal studies.
Results
Establishment of the experimental design and OAB rat model
To systematically evaluate the therapeutic effects of resistance exercise on overactive bladder (OAB), a structured experimental design was established (Fig. 1A). Female Sprague–Dawley rats were divided into control and OAB model groups.
OAB was induced by repeated intraperitoneal injections of cyclophosphamide (CYP), which produced characteristic symptoms of detrusor hyperactivity, including shortened voiding intervals and reduced bladder capacity. Following successful model confirmation, animals in the OAB cohort were subjected to resistance exercise protocols of varying intensities and durations to determine the optimal training regimen.
The study incorporated a multifactorial grouping strategy. OAB rats were allocated into nine exercise subgroups according to three load intensities (5%, 10%, and 15% of body weight, BW) and three training durations (10, 20, or 30 min per day). A non-exercised model group and a blank control group served as negative and baseline references, respectively.
This factorial design enabled comparative assessment of exercise-dose effects on bladder function and tissue remodeling. A comprehensive evaluation system was employed, encompassing three complementary domains: functional evaluation, including urine spot tests, cystometric analysis, and muscle electrophysiology, to assess bladder storage and contractile performance; Imaging evaluation using small-animal magnetic resonance imaging (MRI) to quantify bladder wall and detrusor morphology; Histological evaluation, comprising hematoxylin–eosin (HE) staining, α-smooth muscle actin (α-SMA) immunostaining, and fiber-type identification, to characterize structural and cellular adaptations of the detrusor muscle (Fig. 1A).
The experimental workflow and representative operational setups are illustrated in Fig. 1B–G. Panel B shows the procedure for individual body-weight measurement used to determine relative loading intensity.
Panel C depicts the custom-designed cotton vest with embedded steel compartments that enabled uniform weight distribution during treadmill running. Panel D demonstrates the configuration of the treadmill and exercise enclosure, ensuring stable posture and consistent speed. Figure 1E–G displays actual images of rats performing resistance training at different intensities and the placement of experimental apparatus for parallel group operation.
The integrated design allowed for simultaneous evaluation of exercise efficacy, optimal loading thresholds, and safety, forming the methodological basis for subsequent physiological and molecular analyses.
Resistance exercise protocol and intensity optimization
To determine the optimal exercise intensity for therapeutic intervention, a graded resistance exercise model was established for rats with CYP-induced OAB. The exercise apparatus and custom-made loading system are illustrated in Fig. 2A.
Rats were equipped with adjustable cotton vests embedded with uniformly distributed steel beads, allowing for precise control of external load as a percentage of body weight (BW; 5%, 10%, or 15%). The vests were designed to maintain balance and comfort during treadmill locomotion while minimizing friction or skin irritation. Resistance exercise was conducted on a motorized treadmill (8 m/min) housed within an enclosed acrylic chamber to ensure consistent running posture and environmental control.
Before initiating the formal training protocol, all rats underwent a 7-day acclimatization phase consisting of unloaded treadmill running (5–10 min/day), during which they were gradually adapted to vest wearing and handling procedures. Following adaptation, rats were randomly assigned to resistance exercise regimens that combined three load intensities (5%, 10%, and 15% BW) with three exercise durations (10, 20, and 30 min per day). Each subgroup trained five consecutive days per week for 2 weeks.Fig.
2Establishment and optimization of resistance exercise intensity in the OAB rat model. A Illustration of the custom-designed treadmill resistance training system for rats. The apparatus integrates a motorized running platform with adjustable weight loading via cotton vests containing steel beads, allowing precise control of load as a percentage of body weight (BW).
B Preliminary comparison of different exercise intensities and durations to determine the optimal therapeutic threshold. Bar chart summarizes the effectiveness rate (%) across 11 experimental subgroups varying in load (5–15% BW) and duration (10–30 min per day). The 10% BW for 20 min group (Group 6) exhibited the highest functional improvement (80%) with no adverse events, establishing it as the optimal protocol.
C Summary of experimental grouping and tolerance outcomes during pre-experiment intensity screening. The table lists all 11 groups (Control and OAB Model subgroups), resistance duration, relative load, effectiveness rate, and incidence of adverse events
To assess tolerance, safety, and efficacy, preliminary experiments were performed (Fig. 2B, C). The effectiveness rate was defined as the percentage of rats demonstrating measurable improvement in bladder capacity (≥ 30% increase from model baseline) without adverse symptoms such as immobility, fatigue, or weight loss exceeding 10%.
Adverse events were monitored daily and included activity intolerance, refusal of exercise, and mortality. Groupwise differences for the primary outcomes are summarized in Table 1 (means, 95% CIs, effect sizes, and adjusted p values); Fig. 2C provides representative traces visualizing the qualitative pattern of change.
Medium-intensity training (10% BW, 10–20 min/day) was well-tolerated and yielded the highest functional improvement rate (80%) without mortality or behavioral abnormalities. In contrast, excessive load (≥ 15% BW) or prolonged duration (≥ 30 min/day) markedly increased intolerance (20–60%) and mortality (up to 20%), indicating excessive physiological stress. Based on these data, 10% BW with 20 min of daily training was selected as the optimal protocol for subsequent mechanistic and functional studies.
Urodynamic testing reveals improved bladder capacity and reduced hyperactivity after resistance exercise
To evaluate functional urinary behavior and bladder storage capacity, a urine spot test was performed using metabolic cages with filter paper lining to capture spontaneous voiding patterns (Fig. 3A, B). Representative images of ninhydrin-stained urine spots and quantitative analysis using ImageJ software.
Each spot area (outlined in yellow) reflects a single voiding event (Fig. 3C). After 4 h of observation, the distribution and area of urine spots were visualized with ninhydrin staining and quantitatively analyzed using ImageJ software.Fig.
3Urine spot test evaluation demonstrating functional improvement of bladder storage after resistance exercise. A, B Experimental setup of the urine spot test using individual metabolic cages with filter paper lining for spontaneous urination recording. C Representative images of ninhydrin-stained urine spots and quantitative analysis using ImageJ software.
Each spot area (outlined in yellow) reflects a single voiding event. D, E Quantitative comparison of total urine spot area among groups. Cyclophosphamide (CYP)-induced OAB rats exhibited a markedly enlarged urine spot area compared with controls, indicating urinary frequency and urgency.
Moderate resistance exercise (10% body weight [BW]) significantly reduced total urine spot area, signifying improved bladder capacity and storage function. F Time-course comparison of urine spot patterns on day 1, day 7, and day 14. OAB model rats showed large, diffuse, irregular urine patches throughout, while resistance exercise progressively reduced spot size and diffusion, approaching normal morphology by day 14.
G Quantitative trend of mean urine spot area over time, confirming progressive recovery of bladder compliance and voiding control following 10% BW resistance exercise
Control rats exhibited small, discrete, and regularly spaced urine spots, indicative of normal voiding frequency and intact storage function. In contrast, CYP-induced OAB rats produced large and diffuse urine patches, reflecting increased urinary frequency and urgency. Quantitative analysis confirmed a dramatic enlargement of total urine spot area in the OAB model (38.6 ± 5.2 cm2) compared with controls (8.2 ± 1.5 cm2, p < 0.001; Fig.
3D, E). Resistance exercise at 10% of body weight (BW) significantly ameliorated these abnormalities. After 2 weeks of moderate-intensity training, the mean urine spot area decreased to 14.2 ± 3.1 cm2 (p < 0.01 vs.
OAB model; Fig. 3D, E), accompanied by restoration of spot compactness and reduced peripheral diffusion. The number of voiding episodes within the observation period also decreased, suggesting improved bladder compliance and capacity.
To dynamically assess voiding behavior and bladder storage function, a urine spot test was performed at three timepoints, day 1, day 7, and day 14, after the initiation of resistance exercise. Rats were individually placed in metabolic cages with filter paper for 4 h to record spontaneous urination patterns. At baseline (day 1), both the OAB model and exercise groups exhibited large, diffuse urine spots with irregular boundaries, markedly exceeding those of the control group, indicating severe bladder hyperactivity (Fig.
3F). Quantitatively, the mean urine spot areas were comparable between the OAB model (38.1 ± 5.6 cm2) and the exercise group (36.8 ± 4.9 cm2, p > 0.05), both significantly larger than controls (8.4 ± 1.6 cm2, p < 0.001; Fig. 3G).
By day 7, a notable divergence emerged. The exercise group displayed a pronounced reduction in spot area (20.6 ± 3.8 cm2), representing a 44% decrease relative to the model group (36.9 ± 4.7 cm2, p < 0.01). Morphologically, the urine spots became smaller and more centralized, suggesting partial restoration of voiding control (Fig.
3F, G). At day 14, the therapeutic effect was further consolidated: urine spots in the exercise group approached those of normal controls, with a mean area of 14.2 ± 3.1 cm2, significantly lower than the OAB model (38.6 ± 5.2 cm2, p < 0.001) and not significantly different from controls (p = 0.21; Fig. 3F, G).
The spatial pattern of staining revealed compact and well-defined voiding marks, consistent with normalized bladder storage and reduced urgency.
Across all timepoints, OAB model rats consistently exhibited large urine spots and increased voiding frequency, whereas resistance exercise induced a time-dependent recovery of bladder function, with measurable improvement evident from day 7 and near-complete normalization by day 14. Together, these findings confirm that moderate-intensity resistance exercise (10% BW, 20 min/day) progressively alleviates urinary frequency and improves bladder compliance, demonstrating a reversible and adaptive functional restoration in OAB rats.
Urodynamic assessment of bladder function in OAB rats
Given the improvements observed in voiding patterns from urine spot tests, we next performed urodynamic evaluation to quantify bladder storage and contractile function (Fig. 4A–D). Continuous cystometric recordings under urethane anesthesia provided parameters, including effective bladder capacity (EBC) and voiding interval (VI), which together reflect detrusor compliance and reflex control.Fig.
4Urodynamic assessment showing functional restoration of bladder capacity and voiding interval after resistance exercise. A Schematic diagram of cystometric measurement setup. Intravesical pressure was recorded via a transurethral catheter connected to a pressure transducer, while pelvic floor electromyography (EUS–EMG) was simultaneously obtained through bipolar electrodes.
B Photograph of the urodynamic system used for cystometric recordings and real-time pressure monitoring. C Experimental setup showing rat preparation under urethane anesthesia with transurethral catheterization and continuous saline infusion for cystometry. D Representative cystometric trace illustrating intravesical pressure cycles during bladder filling and voiding phases.
E, F Quantitative analysis of effective bladder capacity (EBC) and voiding interval (VI) across groups. Cyclophosphamide (CYP)-induced OAB rats exhibited a pronounced reduction in EBC and shortened VI compared with controls, indicating detrusor overactivity. Moderate resistance exercise (10% body weight [BW], 20 min/day) significantly improved both parameters, demonstrating restoration of bladder compliance and suppression of hypercontractility. ***p < 0.001, ****p < 0.0001
Representative cystometric traces revealed profound differences among the three groups. Control rats exhibited regular, low-frequency bladder pressure cycles with long storage phases, indicating normal detrusor coordination. In contrast, CYP-induced OAB rats displayed frequent, irregular high-amplitude pressure waves and shortened intercontraction intervals, consistent with detrusor overactivity.
Notably, rats subjected to 10% body weight (BW) resistance exercise showed restored cystometric profiles, characterized by stable baseline pressure, extended voiding intervals, and reduced spontaneous contractions.
Quantitative analysis confirmed these findings (Fig. 4E, F). In OAB model rats, EBC decreased sharply to 0.45 ± 0.17 mL, compared with 1.52 ± 0.36 mL in controls (p < 0.001), while the mean voiding interval was shortened from 7.12 ± 1.03 min to 2.13 ± 0.64 min (p < 0.001).
Following 2 weeks of moderate-intensity resistance exercise (10% BW, 20 min/day), both parameters improved significantly: EBC increased nearly threefold to 1.28 ± 0.44 mL (p < 0.01 vs. OAB), and VI extended to 6.35 ± 0.93 min (p < 0.01 vs. OAB), approaching values observed in the control group.
Higher load intensities (≥ 20% BW) or prolonged training durations failed to elicit further improvement and occasionally resulted in unstable pressure traces, aligning with the diminished tolerance observed during pre-experiment optimization.
Collectively, these urodynamic results confirm that moderate resistance exercise effectively restores bladder capacity, prolongs the voiding interval, and normalizes detrusor activity in OAB rats. Combined with the progressive improvement in urine spot tests, these findings demonstrate that exercise-induced mechanical loading promotes functional remodeling of bladder compliance and voiding control.
Detrusor remodeling
The detrusor muscle (smooth muscle layer responsible for bladder contraction) undergoes pathological thickening in OAB due to chronic hyperactivity. Using small animal MRI and HE staining, OAB rats exhibited detrusor thickness of 0.47 ± 0.03 mm, significantly higher than normal controls (0.14 ± 0.02 mm). Figure 5A–C provides methodological context, including MRI scanner setup, rat positioning, and sagittal view of the bladder with detrusor muscle outlined.
After 10% BW resistance exercise, detrusor thickness was reduced to 0.21 ± 0.03 mm (p < 0.05 vs. OAB model); Fig. 5D, approaching normal levels.Fig.
5MRI-based assessment of detrusor muscle remodeling after resistance exercise. A Photograph of the 7.0 T small-animal magnetic resonance imaging (MRI) system used for non-invasive evaluation of bladder wall morphology. B Experimental setup showing rat positioning in an MRI-compatible holder with pelvic immobilization to ensure image stability.
C Representative T2-weighted sagittal MRI image of the pelvic region. The bladder and detrusor muscle layers are delineated manually (white outline). OAB model rats exhibited marked detrusor thickening compared with controls, while resistance exercise (10% body weight [BW]) markedly reduced detrusor thickness.
D Quantitative comparison of detrusor thickness among groups. The OAB model group displayed significant smooth muscle hypertrophy (0.47 ± 0.03 mm) relative to controls (0.14 ± 0.02 mm; p < 0.001), whereas 10% BW resistance exercise decreased detrusor thickness to 0.21 ± 0.03 mm (p < 0.001 vs. OAB model), indicating reversal of pathological muscle remodeling. ***p < 0.001, ****p < 0.0001
Metabolomics and oxidative stress in OAB rat models
In the analysis of metabolomics, the global metabolic feature distribution of three groups of samples was first assessed using principal component analysis (PCA) and partial least squares–discriminant analysis (PLS–DA). The PCA results indicated a certain degree of differentiation among the Normal group, the Overactive Bladder (OAB) group, and the Treatment group along the first and second principal component dimensions, suggesting differences in the metabolic profiles of each group. The PLS–DA analysis further enhanced the discriminative ability between groups, with distinct separations observed in multi-dimensional space, indicating that the treatment intervention may have a systemic impact on the metabolic profiles (Fig.
6A, B).Fig. 6Metabolomic profiling and pathway enrichment analysis reveal redox-associated metabolic reprogramming following resistance exercise. A, B Principal component analysis (PCA) and partial least squares–discriminant analysis (PLS–DA) plots showing distinct clustering among normal, OAB, and Treatment (10% body weight [BW] resistance exercise) groups.
The clear group separation indicates substantial metabolic alterations induced by both OAB pathology and exercise intervention. C Heatmap and Z-score distribution of representative differential metabolites. OAB rats displayed elevated levels of oxidative stress-related metabolites (e.g., glutamate and arginine), whereas resistance exercise normalized these disturbances, indicating restoration of redox balance and nitrogen metabolism.
D Volcano plot showing significantly altered metabolites between Treatment and OAB groups (red dots, p < 0.05, |log₂FC|> 1), highlighting exercise-induced metabolic normalization. E KEGG pathway enrichment analysis of differential metabolites. Major pathways restored by resistance exercise include glutathione metabolism, arginine and proline metabolism, glycine–serine–methionine metabolism, and the TCA cycle.
These pathways are closely linked to oxidative stress regulation, NO/PN homeostasis, and mitochondrial redox control, supporting a mechanistic role for peroxynitrite reduction and antioxidant pathway activation in bladder function recovery. p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
The representative metabolites upregulated in the Treatment group include: butanedione glycol, hydantoin-5-propionic acid, syringic acid, gabapentin, glycerone triphosphate, theophylline, triglyceride, ADP, ASP, dichlorophenyl-bis-triazolylpropanol, phenylacetic acid, indole-3-propionic acid, glutamic acid, malic acid, lipoic acid, and p-cresol. These metabolites are involved in key functional processes, such as neuro-regulation, nucleotide metabolism, lipid metabolism, as well as antioxidant defense, gut microbiota metabolism, and the TCA cycle. These changes suggest that the treatment may have activated a series of metabolic regulatory networks, thereby reshaping local or systemic metabolic states (Fig.
6C). In further differential metabolite analysis, we compared the metabolic changes between the Treatment group and the other groups (Fig. 6D).
The KEGG pathway enrichment analysis revealed that these metabolites were significantly enriched in several key metabolic pathways (Fig. 6E), including glutathione metabolism, glycine–serine metabolism, methionine degradation, alanine metabolism, urea cycle, and tyrosine metabolism. These pathways are widely involved in oxidative stress response, nitrogen balance regulation, immune metabolism, and cellular protective mechanisms, suggesting that therapeutic interventions may improve the pathological state of OAB by enhancing antioxidant capacity, regulating amino acid metabolic balance, and promoting urethral barrier repair.
Discussion
Resistance exercise represents a promising, mechanism-based strategy for improving bladder function in overactive bladder (OAB), yet its underlying molecular pathways have remained unclear [22, 23]. Nonetheless, its clinical application remains constrained by the absence of standardized training protocols. Conventional regimens, such as simple pelvic floor muscle training achieve limited success, with effectiveness rates averaging only 42% [24].
In this study, we demonstrated that low-intensity resistance exercise (10% body weight, 20 min/day) significantly ameliorated detrusor overactivity and restored bladder capacity in a cyclophosphamide (CYP)-induced OAB rat model. Functionally, resistance exercise prolonged voiding intervals, increased effective bladder capacity, and normalized urinary frequency, while structurally it reduced detrusor muscle hypertrophy as confirmed by MRI and histological analyses. Importantly, metabolomic profiling revealed that resistance exercise corrected redox-related metabolic disturbances, particularly in glutathione and arginine biosynthesis pathways, suggesting a mechanistic link between controlled mechanical loading and oxidative stress regulation.
These findings identify peroxynitrite (ONOO⁻) suppression and redox homeostasis restoration as central mediators of the therapeutic effects of resistance exercise on OAB [25].
This study establishes a novel mechanistic axis combining “resistance exercise, peroxynitrite reduction, oxidative stress attenuation, and detrusor remodeling” that bridges mechanical training with biochemical modulation of bladder function. In OAB, excessive nitric oxide (NO) and superoxide (O₂⁻) production leads to peroxynitrite formation, resulting in nitrative protein damage, mitochondrial dysfunction, and smooth muscle hypercontractility [26]. Our findings demonstrate that resistance exercise counteracts this pathological process by rebalancing NO metabolism, decreasing peroxynitrite accumulation (evidenced by reduced 3-nitrotyrosine staining), and restoring glutathione-dependent antioxidant capacity.
The accompanying improvement in urodynamic parameters supports the physiological relevance of this redox-mediated remodeling [27]. These results collectively suggest that controlled, low-intensity resistance exercise can normalize detrusor biomechanics through redox reprogramming, providing a mechanistic foundation for the clinical application of personalized exercise prescriptions in OAB management.
At the molecular level, metabolomic analysis revealed profound dysregulation of pathways related to NO synthesis and oxidative stress in OAB rats. In particular, alterations were also evident in arginine biosynthesis, a pathway intimately linked to NO production [28, 29]. Arginine serves as the direct substrate for NO synthase, while glutamate contributes to arginine metabolism and indirectly influences NO synthesis [30].
OAB is characterized by dysregulated NO synthesis, driven by metabolic disturbances in arginine biosynthesis. In OAB rats, arginine and glutamate levels (substrates for NO production) increased by 1.8-fold and 2.1-fold, respectively, leading to excessive NO generation via iNOS. Excess NO, in combination with NOX1-derived superoxide (O2·⁻), forms PN, a cytotoxic oxidant that induces protein nitration (e.g., 3-nitrotyrosine modification) and impairs detrusor contractility [31, 32].
Resistance exercise normalizes arginine and glutamate levels, downregulates iNOS/NOX1 expression, and reduces PN formation [33, 34]. This metabolic adjustment aligns with improved EBC and voiding interval, as balanced NO signaling restores detrusor muscle compliance and contractile coordination. In OAB rats, arginine levels increased 1.8-fold and glutamate levels 2.1-fold compared with controls, reflecting heightened substrate availability for NO generation.
Such overproduction of NO has been implicated in detrusor hypercontractility, where excessive smooth muscle excitability leads to increased voiding frequency and reduced bladder capacity. Following resistance exercise, both arginine and glutamate concentrations normalized, indicating a downregulation of NO overproduction. The attenuation of ROS further propagates anti-inflammatory effects.
Excessive ROS in OAB activates the nuclear factor-kappa B (NF-κB) signaling pathway, a master regulator of pro-inflammatory gene expression [35, 36], leading to upregulation of cytokines, such as IL-6 and IL-8. These cytokines promote detrusor hypercontractility and nerve sensitization, exacerbating urinary urgency and frequency. Resistance exercise interrupts this “oxidative stress-inflammation” feedback loop by reducing ROS, thereby inhibiting NF-κB activation [37, 38].
This anti-inflammatory effect further supports the role of resistance exercise in resolving chronic bladder tissue damage and restoring smooth muscle quiescence.
Unlike conventional antioxidant responses that broadly lower reactive oxygen species (ROS) such as superoxide and hydrogen peroxide through enzymatic upregulation (SOD, CAT, and GPx), peroxynitrite (ONOO⁻) represents a unique nitro-oxidative mediator formed by the rapid diffusion-limited reaction between NO and O₂⁻ [37, 38]. This reactive species causes protein tyrosine nitration (3-nitrotyrosine formation), leading to irreversible inactivation of contractile and mitochondrial enzymes, including SERCA2a, MnSOD, and ATPase, thereby directly impairing detrusor relaxation and energy homeostasis. Resistance exercise modulates this pathway not by indiscriminately suppressing ROS, but by re-coupling eNOS activity, reducing O₂⁻ substrate availability, and preserving NO bioactivity, which together constrain ONOO⁻ generation [37, 38].
Consequently, the intervention re-establishes the nitro-redox equilibrium rather than inducing a nonspecific antioxidant state. The mechanistic distinction positions peroxynitrite modulation as a novel therapeutic target, highlighting resistance exercise as a physiological approach to rebalance NO/ROS signaling in overactive bladder pathology.
Following resistance exercise, these metabolites normalized, implying reduced NO overproduction and restoration of physiological signaling balance. Mechanical loading during graded resistance exercise is likely perceived by detrusor smooth-muscle and stromal cells via integrin–focal adhesion complexes. Downstream FAK/Src and PI3K/Akt signaling can facilitate Nrf2 release from Keap1, promoting nuclear translocation and transcription of antioxidant programs (e.g., HO-1, NQO1, SOD, and GPx) [39].
In parallel, moderate exercise is known to enhance physiological eNOS phosphorylation and diminish eNOS uncoupling, normalizing NO bioavailability. By lowering superoxide and restoring NO signaling, the reaction stoichiometry favoring peroxynitrite (ONOO⁻) formation is weakened, providing a plausible explanation for the reduced 3-nitrotyrosine we observed [40]. While this study did not dissect each node experimentally, this integrated mechano-redox framework parsimoniously links exercise-evoked forces to the antioxidant phenotype in bladder tissues.
In OAB models, PN accumulation was confirmed by increased 3-NT staining, while resistance exercise markedly reduced PN levels, supporting its capacity to mitigate oxidative and inflammatory burden. This protective effect is consistent with prior evidence that exercise activates the Nrf2 antioxidant pathway, upregulates detoxifying enzymes, and accelerates ROS clearance, collectively restoring redox homeostasis. Alterations were also evident in arginine biosynthesis, a pathway intimately linked to NO production [28, 29].
The convergence of these results supports a unifying model in which low-intensity resistance exercise improves bladder function by reducing oxidative stress, suppressing PN-mediated injury, and facilitating adaptive smooth muscle remodeling [41].
First, while 3-nitrotyrosine supports a peroxynitrite-centered redox mechanism, other ROS (e.g., superoxide, hydrogen peroxide, and mitochondrial ROS) may also participate in detrusor remodeling. Second, definitive causality would require pharmacological ONOO⁻ scavenging (e.g., FeTMPyP and uric acid) or genetic approaches, which were beyond the scope of this revision but will be prioritized. Third, the intervention window and species/sex specificity limit generalizability; future work will extend observation periods, include both sexes, and incorporate targeted perturbations guided by metabolomic readouts.
Besides, although untargeted metabolomics revealed alterations in antioxidant and arginine metabolism pathways, the quantification is relative and lacks targeted LC–MS/MS validation using authentic standards. Future work will apply targeted assays to confirm changes in GSH/GSSG ratio, arginine–NO flux, and related intermediates.
Clinically, the translational potential of these findings is significant. From a translational perspective, the identified mechano-redox axis, integrating mechanical sensing (integrin–FAK–PI3K/Akt) with nitro-redox regulation (Nrf2–eNOS coupling), may inform the design of biomarker-guided clinical trials for overactive bladder. Moderate-intensity resistance training protocols that restore NO/ONOO⁻ balance in animals could be adapted into individualized exercise prescriptions, while circulating 3-nitrotyrosine, NOx, and GSH/GSSG ratios may serve as surrogate endpoints to monitor redox re-equilibration.
Such translation could bridge mechanistic insights with practical, non-pharmacologic interventions for bladder dysfunction. Resistance exercise at 10% BW represents a safe, scalable intervention, particularly suited for older adults who may be vulnerable to musculoskeletal injury. Previous clinical studies corroborate its efficacy, showing that combining resistance elements with pelvic floor training increases OAB treatment success from 42 to 71% [42].
The present preclinical data provide mechanistic underpinnings for these clinical outcomes, highlighting PN reduction as a key therapeutic target. Nevertheless, while PN reduction appears to be a dominant pathway, causal validation will require pharmacological studies employing PN-specific inhibitors, such as FeTMPyP. Moreover, although the comprehensive 11-group design strengthened the comparative analysis, subgroup sample sizes limited statistical power for evaluating finer variables, such as duration effects.
Future research should, therefore, focus on dose–response dynamics of PN regulation, long-term adherence to exercise regimens, and combined strategies integrating pharmacological and behavioral interventions.
Conclusion
In summary, this study demonstrates that low-intensity resistance exercise alleviates overactive bladder (OAB) by reducing peroxynitrite-mediated oxidative stress and promoting adaptive detrusor remodeling. Moderate mechanical loading (10% body weight, 20 min/day) restored bladder capacity, prolonged voiding intervals, and reversed smooth muscle hypertrophy in a cyclophosphamide-induced OAB model. Metabolomic analysis revealed normalization of glutathione and arginine pathways, indicating restoration of redox balance.
These findings define a “resistance exercise–oxidative stress–detrusor remodeling” axis and support resistance exercise as a safe, non-pharmacological strategy for OAB management, offering mechanistic insight for personalized exercise prescriptions in clinical practice.
Supplementary Information
Supplementary material 1. Supplementary material 2.